BIOPHARMA RESEARCH LTDActive

Company number 08243684Private limited companyIncorporated 2012

Key figures

£6,054-81.1%
Net assets 2025/26
+67.2%
Average annual growth 2020/21–2025/26
010 k20 k30 k40 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, BIOPHARMA RESEARCH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand————8,045
Total assets74,44160,40674,05499,795—
Total liabilities74,41459,880———
Net assets / total equity2752621,07032,0086,054
Average number of employees11122

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principle activity of the company during the financial year was that of information service activities

As described in the company's latest filed accounts.

Summary: BIOPHARMA RESEARCH LTD

Company

BIOPHARMA RESEARCH LTD is a private limited company registered with Companies House under company number 08243684. It was incorporated on 8 Oct 2012. Its status is active. The registered office is in Westgate (DL13). Its nature of business (SIC 2007) is other information service activities n.e.c. (63990).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £6,054, down 81.1% on the previous year. Cash at bank and in hand was £8,045. The company had an average of 2 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 9 Dec 2026.